Image_3_SPINT1-AS1 Drives Cervical Cancer Progression via Repressing miR-214 Biogenesis.TIF
Accumulating evidences have revealed the dysregulated expressions and critical roles of non-coding RNAs in various malignancies, including cervical cancer. Nevertheless, our knowledge about the vast majority of non-coding RNAs is still lacking. Here we identified long non-coding RNA (lncRNA) SPINT1-AS1 as a novel cervical cancer-associated lncRNA. SPINT1-AS1 was increased in cervical cancer and correlated with advanced stage and poor prognosis. SPINT1-AS1 was a direct downstream target of miR-214, a well-known tumor suppressive microRNA (miRNA) in cervical cancer. Intriguingly, SPINT1-AS1 was also found to repress miR-214 biogenesis via binding DNM3OS, the primary transcript of miR-214. The interaction between SPINT1-AS1 and DNM3OS repressed the binding of DROSHA and DGCR8 to DNM3OS, blocked DNM3OS cleavage, and therefore repressed mature miR-214 biogenesis. The expression of SPINT1-AS1 was significantly negatively correlated with miR-214 in cervical cancer tissues, supporting the reciprocal repression between SPINT1-AS1 and miR-214 in vivo. Through downregulating mature miR-214 level, SPINT1-AS1 upregulated the expression of β-catenin, a target of miR-214. Thus, SPINT1-AS1 further activated Wnt/β-catenin signaling in cervical cancer. Functionally, SPINT1-AS1 drove cervical cancer cellular proliferation, migration, and invasion in vitro, and also tumorigenesis in vivo. Deletion of the region mediating the interaction between SPINT1-AS1 and DNM3OS, overexpression of miR-214, and inhibition of Wnt/β-catenin signaling all reversed the roles of SPINT1-AS1 in cervical cancer. Collectively, these findings identified SPINT1-AS1 as a novel cervical cancer-associated oncogenic lncRNA which represses miR-214 biogenesis and activates Wnt/β-catenin signaling, highlighting its potential as prognostic biomarker and therapeutic target for cervical cancer.
History
References
- https://doi.org//10.1016/j.ccell.2018.03.014
- https://doi.org//10.3389/fcell.2020.00461
- https://doi.org//10.3389/fcell.2020.00474
- https://doi.org//10.1016/j.canlet.2019.06.015
- https://doi.org//10.1038/s41556-020-0572-2
- https://doi.org//10.3389/fcell.2018.00078
- https://doi.org//10.1016/j.ccell.2019.01.019
- https://doi.org//10.3389/fcell.2021.634512
- https://doi.org//10.3389/fonc.2020.01433
- https://doi.org//10.1038/ng.3192
- https://doi.org//10.1007/s11033-020-05798-5
- https://doi.org//10.2147/OTT.S163883
- https://doi.org//10.1186/s12943-017-0681-0
- https://doi.org//10.1111/jcmm.14706
- https://doi.org//10.3389/fcell.2020.592868
- https://doi.org//10.1016/j.ccell.2019.10.011
- https://doi.org//10.1038/s41419-020-2338-y
- https://doi.org//10.1038/s41556-019-0272-y
- https://doi.org//10.1016/j.gene.2019.144146
- https://doi.org//10.1155/2020/6634247
- https://doi.org//10.1038/jid.2011.481
- https://doi.org//10.1111/febs.14666
- https://doi.org//10.1164/rccm.201807-1237OC
- https://doi.org//10.1093/nar/gkz1051
- https://doi.org//10.3322/caac.21660
- https://doi.org//10.1096/fj.202002108R
- https://doi.org//10.1016/j.omtn.2019.10.041
- https://doi.org//10.1038/s41556-019-0292-7
- https://doi.org//10.1080/17460441.2018.1443074
- https://doi.org//10.3390/cancers10100353
- https://doi.org//10.1038/s41419-020-03018-3
- https://doi.org//10.3389/fgene.2019.00025
- https://doi.org//10.3892/ol.2018.9363
- https://doi.org//10.1038/ncb3538
- https://doi.org//10.1002/hep.24606
- https://doi.org//10.1016/j.ccr.2014.03.010
- https://doi.org//10.1080/15476286.2020.1819670
- https://doi.org//10.1038/s41556-020-00595-5
- https://doi.org//10.1186/s12943-019-0999-x
- https://doi.org//10.1016/j.prp.2020.153268
- https://doi.org//10.1111/febs.13839
CC BY 4.0